Back

Impact of intensive low-density lipoprotein cholesterol lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome

31 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (2) Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kazuyoshi Kakehi

Kindai University Hospital, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Prevalence of subclinical atheromatosis in low-intermediate cardiovascular risk patients with atrial fibrillation
Doctor M. Fernandez Recalde (Ciudad Autonoma De Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Lipid disorder and Inflammation in coronary artery disease: clinical implications on concordance/discordance of RC, LDL and hsCRP
Associate Professor L. Bikdelu (Mashhad, IR)
Abstract Slides Video
Presentation thumbnail
Associations between health literacy, socio-demographics and health behaviours in adults with myocardial infarction: a cross-sectional analysis of the ENHEARTEN Study
Doctor D. Azar (Warragul, AU)
Abstract Slides Video
Presentation thumbnail
Long-term impact of telemedicine for lipid control after an acute coronary syndrome
Mr C. Jimenez Mendez (Cadiz, ES)
Abstract Slides Video
Presentation thumbnail
Missed opportunity in primary prevention: an analysis of acute myocardial infarction patients with no history of atherosclerotic cardiovascular disease
Professor N. Danchin (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources